Opsy Competitors and Similar CompaniesClear all
Opsy's competitors and similar companies include Indaptus Therapeutics, OnCusp Therapeutics, Mallinckrodt Pharmaceuticals and Dendreon.
 Opsy Opsy Holding (formerly WntResearch) is a biotech company that develops therapies for preventing cancer spread. |  Indaptus Therapeutics Indaptus Therapeutics. is a biopharmaceutical company that specializes in cancer and other infectious disease treatment solutions. |  OnCusp Therapeutics OnCusp Therapeutics is a biopharmaceutical company that specializes in cancer treatment solutions. |  Mallinckrodt Pharmaceuticals Mallinckrodt is a business that develops, manufactures, markets and distributes specialty pharmaceutical and biopharmaceutical products and therapies. |  Dendreon Dendreon Pharmaceuticals (formerly known as Activated Cell Therapy) is a biopharmaceutical company that engages in the development of immunotherapy. | |
Founding Date | Founding Date 2007 | Founding Date 2021 | Founding Date 2021 | Founding Date 1867 | Founding Date 1992 |
Type | Type Public | Type Public | Type Private | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations Gothenburg, SE HQ Lund, SE | Locations HQ | Locations New York, US HQ Shanghai, CN Shanghai, CN | Locations Dublin 15, IE HQ Staines, GB Hazelwood, US Webster Groves, US | Locations Seal Beach, US HQ Seattle, US Union City, US Tampa, US |
Employees | Employees 2 | Employees N/A | Employees 2519% increase | Employees 3,373 | Employees 6131% decrease |
Valuation ($) | Valuation ($) 721.5 k | Valuation ($) 12.6 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) kr6.7m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $1b (FY, 2022) | Revenue (est.) N/A |
Cost of goods | Cost of goods kr1.3m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods $643.5m (FY, 2022) | Cost of goods N/A |
Gross profit | Gross profit kr5.4m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit $396.2m (FY, 2022) | Gross profit N/A |
Net income | Net income (kr17.2m) (FY, 2025) | Net income N/A | Net income N/A | Net income ($598.3m) (FY, 2022) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Indaptus Therapeutics
HQ
Indaptus Therapeutics. is a biopharmaceutical company that specializes in cancer and other infectious disease treatment solutions.
View companyOnCusp Therapeutics
HQ
New York, US
Employees
25↑ 19% increase
OnCusp Therapeutics is a biopharmaceutical company that specializes in cancer treatment solutions.
View companyMallinckrodt Pharmaceuticals
HQ
Dublin 15, IE
Employees
3,373
Mallinckrodt is a business that develops, manufactures, markets and distributes specialty pharmaceutical and biopharmaceutical products and therapies.
View companyDendreon
HQ
Seal Beach, US
Dendreon Pharmaceuticals (formerly known as Activated Cell Therapy) is a biopharmaceutical company that engages in the development of immunotherapy.
View company